510(k) · Cleared
ClearedPuraStat-GI
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
3-D Matrix, Inc. · QAU Hemostatic Device For Endoscopic Gastrointestinal Use
Cleared on Jun 25, 2021 as substantially equivalent to DEN170015 (Wilson-Cook Medical, Inc., 2018) after a 162-day review. Its family tree reaches back 1 generation to 2018. 4 later devices descend from it.
- Decided
- Jun 25, 2021
- Review
- 162 days
- Class
- Class II
- Product code
- QAU
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 1 generation to DEN170015 (2018). 4 later devices descend from it, 1 citing it directly.
- Root · 1 generation backDEN170015 Hemospray Endoscopic HemostatWilson-Cook Medical, Inc. · 2018
- This deviceK210098 PuraStat-GI3-D Matrix, Inc. · 2021
- Descendant · cites it directly · 3 of its ownK222481 PuraStat3-D Matrix, Inc. · 2023
- Descendant · 2 generations on · 2 of its ownK242250 PuraStat3-D Matrix Europe SAS · 2024
- Descendant · 3 generations on · 1 of its ownK253924 PuraStat3-D Matrix Europe SAS · 2026
- Descendant · 3 generations on · 0 of its ownK261503 PuraStat GI3-D Matrix, Inc. · 2026
Most influential descendants
Showing 4 of 4 · See allView FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | DEN170015 | Hemospray Endoscopic Hemostat | Wilson-Cook Medical, Inc. | 2018 | — |
| 0 (this device) | K210098 | PuraStat-GI | 3-D Matrix, Inc. | 2021 | — |
| +1 | K222481 | PuraStat | 3-D Matrix, Inc. | 2023 | — |
| +2 | K242250 | PuraStat | 3-D Matrix Europe SAS | 2024 | — |
| +3 | K253924 | PuraStat | 3-D Matrix Europe SAS | 2026 | — |
| +3 | K261503 | PuraStat GI | 3-D Matrix, Inc. | 2026 | — |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2023 | 1 | 0 |
| 2024 | 1 | 0 |
| 2026 | 2 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in QAU? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new QAU device
- #1 K242250 PuraStatscore 14.8 · 3 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | DEN170015 | Hemospray Endoscopic HemostatSummary page 4…Class: II Product Code: QAU Panel: General & Plastic Surgery 3. PREDICATE DEVICE Predicate Device: Wilson-Cook Medical, Inc.’s Hemospray® Endoscopic Hemostat (DEN170015) Reference Device: 3-D Matrix, Inc.’s PuraDerm Gel (K143058) 4. DEVICE DESCRIPTION PuraStat-GI is a sterile gel compos… | 2018 |
| † | K143058 | PuraDerm Gel | 2015 |
What descends from it? (4)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K222481 | PuraStat | 2023 | 3 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
How does its category compare?
All QAU devicesQAU Hemostatic Device For Endoscopic Gastrointestinal Use: FDA decisions, review times, recalls and adverse event reports over 20 years. 2021, this device’s year, is highlighted.
FDA decisions per year · QAU
3in 2024
2026 to Oct 25, outlined.
Median 510(k) review, days · QAU
211in 2024
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · QAU
2in 2024
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · QAU
121in 2025
MAUDE reports naming product code QAU, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 0 | — | 0 | 0 |
| 2013 | 0 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 0 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 0 | — | 0 | 0 |
| 2018 | 1 | — | 0 | 56 |
| 2019 | 0 | — | 0 | 218 |
| 2020 | 1 | — | 0 | 73 |
| 2021 | 2 | — | 0 | 112 |
| 2022 | 1 | — | 0 | 135 |
| 2023 | 1 | — | 0 | 132 |
| 2024 | 3 | 211 | 2 | 154 |
| 2025 | 0 | — | 0 | 121 |
| 2026 | 3 | 89 | 1 | — |
What is it indicated for?
PuraStat-GI is intended for hemostasis of mild and moderate bleeding post ESD or EMR, as an adjunct, bridge, prophylactic or rescue therapy for intraprocedural venous bleeding or prophylactic therapy to prevent post procedure bleeding.
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K210098 · printed Nov 6, 2026
Cite this page
510(k) Report. “K210098: PuraStat-GI.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K210098
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026